Form 8-K - Current report:
SEC Accession No. 0001144204-14-072471
Filing Date
2014-12-05
Accepted
2014-12-05 09:02:14
Documents
4
Period of Report
2014-12-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v395914_8k.htm 8-K 17981
2 EXHIBIT 10.1 v395914_ex10-1.htm EX-10.1 60381
3 EXHIBIT 10.2 v395914_ex10-2.htm EX-10.2 37545
4 EXHIBIT 99.1 v395914_ex99-1.htm EX-99.1 2902
  Complete submission text file 0001144204-14-072471.txt   120325
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17263 | Film No.: 141267883
SIC: 2836 Biological Products, (No Diagnostic Substances)